Results 211 to 220 of about 395,110 (339)
Resuscitation of the newborn. An improved neonatal resuscitator.
Insufflatory resuscitation of a newborn baby that has not breathed presents many problems. These are dependent not only on the size and prematurity of the neonate, but on the amount of fluid which is present in the alveoli of the lungs, and the absence of the functional residual capacity (FRC).
openaire +2 more sources
Exploring exosome profiling via CytoFLEX Nano flow cytometer: Approaches and applications
This study evaluated CytoFLEX Nano flow cytometer's exosome detection performance, comparing it with traditional CytoFLEX in sensitivity, repeatability, and fluorescence labeling. Notably, the CytoFLEX Nano demonstrates distinct advantages: enhanced sensitivity, improved selectivity, and expanded applicability.
Li Cao +10 more
wiley +1 more source
A portable dry-electrode ECG device for rapid and accurate neonatal heart rate monitoring during resuscitation. [PDF]
Abdou A, Mistry N, Krishnan S.
europepmc +1 more source
Organ Medicine: Fostering a Hub of Original Innovation to Drive the Life and Health Industry
Organ Medicine, EarlyView.
Yue Yang, Qiang Zhao
wiley +1 more source
Pneumoperitoneum in two cats treated with trilostane for hypercortisolism
Abstract This report describes two cases of pneumoperitoneum in cats receiving treatment for hypercortisolism and diabetes mellitus. Both cats presented with abdominal distention and lethargy and diagnoses of pneumoperitoneum were radiographically confirmed.
Nicholas James Kelly +4 more
wiley +1 more source
Optimizing Fluid Resuscitation Strategies: A Network Meta-analysis of Effectiveness and Safety for Hemorrhagic Shock Patients in Emergency Settings. [PDF]
Aldian FM +8 more
europepmc +1 more source
The frame of survival for cardiopulmonary resuscitation in lower-resource settings [PDF]
Gayathri Devi Nadarajan +1 more
openalex +1 more source
Early TXA administration (≤ 3 h) in concurrent hemorrhage and TBI was significantly associated with a 22% reduction in mortality at 7 days. TXA treatment was also associated with a significant 29% lower odds of organ failure and non‐significant 11% odds of good neurologic recovery.
Julia M. Dixon +13 more
wiley +1 more source

